Suchergebnisse - "Claxton, David"

PubPharm (33)

1

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

enthalten in: Leukemia | 2024

von Garcia-Manero, G. | Podoltsev, N. | Othus, M. | +23

2

Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells

enthalten in: Cell reports | 2023

von Qian, F. | Nettleford, S. | Zhou, J. | +15

3

The impact of early PEG-asparaginase discontinuation in young adults with ALL : a post hoc analysis of the CALGB 10403 study

enthalten in: Blood advances | 2023

von Aldoss, I. | Yin, J. | Wall, A. | +13

4

IMPROVE-BMT : a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients

enthalten in: BMJ open | 2023

von Potiaumpai, M. | Schmitz, K. | Mineishi, S. | +8

5

Subtype-specific 3D genome alteration in acute myeloid leukaemia

enthalten in: Nature | 2022

von Xu, J. | Song, F. | Lyu, H. | +26

6

Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2022

von Khokhlatchev, A. | Sharma, A. | Deering, T. | +13

7

Harnessing the power of sphingolipids : Prospects for acute myeloid leukemia

enthalten in: Blood reviews | 2022

von Ung, J. | Tan, S. | Fox, T. | +13

8

Acute Myeloid Leukemia Stem Cells : Origin, Characteristics, and Clinical Implications

enthalten in: Stem cell reviews and reports | 2022

von Long, N. | Golla, U. | Sharma, A. | +1

CommentIn: Stem Cell Rev Rep. 2022 Apr;18(4):1209-1210. - PMID 35286595

9

A novel clinically relevant graft-versus-leukemia model in humanized mice

enthalten in: Journal of leukocyte biology | 2022

von Jia, B. | Zhao, C. | Bayerl, M. | +11

10

Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2022

von Fisher-Wellman, K. | Hagen, J. | Kassai, M. | +11